Why Glycomimetics Will Have Successful Data Read-Outs

In this 46:30 audio, Danny Cohen and myself discuss why we believe $GLYC will see successful data-read outs in all studies of Uproleselan (GMI-1271). In a general sense, it makes perfect sense to be short here and predict failure. We make the case why to short this is a mistake in the specific sense, and why the company will success here. Bears to date, cannot make a specific case based on the science and previous data why Uproleselan will fail - enjoy the audio!